Turku Bioscience Centre

Turku Bioscience is an advanced core facility and research centre hosted jointly by University of Turku and Åbo Akademi University.

Our Expertise. Your Discoveries.

Research Services

News

Guillaume Jacquemet appointed to K. Albin Johansson Research Professorship

June 19, 2025

Associate Professor, InFLAMES PI Guillaume Jacquemet (Åbo Akademi University) and our affiliated Group Leader has been appointed to a prestigious five-year K. Albin Johansson Research...

Meng Wang (Mona) Successfully Defended PhD on Novel Immune and Genetic Drivers of Melanoma

June 16, 2025

Meng Wang from our affiliated Figueiredo Lab (MIORG) successfully defended her PhD thesis “Novel Immune and Genetic Drivers of Melanoma: Integrative and New Preclinical Models...

cancer Melanoma

Researchers elucidate the role of jaundice during malaria as a metabolic response against Plasmodium infection

June 13, 2025

Researchers from the Turku Bioscience Centre at the University of Turku in Finland collaborated with a leading malaria research group at Gulbenkian Institute of Molecular...

Karoliina Hirvonen Successfully Defended PhD on Serum Proteome and Enterovirus Research

May 23, 2025

Karoliina Hirvonen from Riitta Lahesmaa lab defended her PhD thesis “Proteomics Insights into Type 1 Diabetes Development – Investigating Changes in Serum Proteome and the Role...

Finnish Science Award to Professor Johanna Ivaska

May 20, 2025

The Finnish Science Award 2025 has been awarded to Johanna Ivaska, Professor of Molecular Cell Biology at the University of Turku. The multidisciplinary research group...

cancer Ministry of Education and Culture

Inna Starskaia Successfully Defends PhD Thesis on Early Immune Response in Type 1 Diabetes

May 19, 2025

Inna Starskaia from Riitta Lahesmaa lab succesfully defended her PhD thesis “Early immune response in children developing type 1 diabetes” on Friday the 15th of...

immunology Type 1 Diabetes

All news

Events

34th BioCity Symposium: Transforming drug development for tomorrow

August 28, 2025

More Info

August 28, 2025 - August 29, 2025 @ 8:30 am - 5:00 pm - The 34th BioCity Symposium focuses on drug development across a range of...

Frontiers of Science: Prof. Hiroki Ueda

September 18, 2025

More Info

September 18, 2025 @ 12:00 pm - 1:00 pm - 18th September at 12:00 Onsite event in Presidentti auditorium, BioCity Autumn 2025 program Prof. Hiroki...

Frontiers of Science: Prof. Olli Kallioniemi

October 2, 2025

More Info

October 2, 2025 @ 12:00 pm - 1:00 pm - 2nd October at 12:00 Onsite event in Presidentti auditorium, BioCity Autumn 2025 program Prof. Olli...

Frontiers of Science: Prof. Pere Roca-Cusachs

October 9, 2025

More Info

October 9, 2025 @ 12:00 pm - 1:00 pm - 9th October at 12:00 Onsite event in Presidentti auditorium, BioCity Autumn 2025 program Prof. Pere...

BioCity Turku Guest Seminar: Prof. Mark Daly

October 21, 2025

More Info

October 21, 2025 @ 12:00 pm - 1:00 pm - 21st October at 12:00-13:00 Onsite event in Presidentti auditorium, BioCity Prof. Mark Daly, Massachusetts General...

Turku Imaging Day 2025

October 22, 2025

More Info

October 22, 2025 @ 9:00 am - 5:00 pm - 22nd October, whole-day event Onsite event in Holiday Club Caribia, Turku Save the date from...

All events

Recent Publications

The Next Frontier: Unveiling Novel Approaches for Combating Multidrug-Resistant Bacteria

Praveen Mallari et al.

Pharm Res. 2025 Jun 16. doi: 10.1007/s11095-025-03871-x. Online ahead of print.

Monday, June 16, 2025

CONCLUSION: Despite the substantial obstacles to getting bench findings to the patient, numerous scientists are still working towards this goal. Both the application of antibiotic stewardship principles and timely considerations...

A metabolite-based resistance mechanism against malaria

Ana Figueiredo et al.

Science. 2025 Jun 12;388(6752):eadq6741. doi: 10.1126/science.adq6741. Epub 2025 Jun 12.

Thursday, June 12, 2025

Jaundice is a common presentation of Plasmodium falciparum malaria, which arises from the accumulation of circulating bilirubin. It is not understood whether it represents an adaptive or maladaptive response to...

NRF2-mediated persistent adaptation of oesophageal adenocarcinoma cells to HER2 inhibition

Wei Zhang et al.

Oncogene. 2025 Jun 5. doi: 10.1038/s41388-025-03459-0. Online ahead of print.

Thursday, June 5, 2025

The human epidermal growth factor receptor 2 (HER2, also known as ERBB2) is a commonly over-expressed oncoprotein in oesophageal adenocarcinoma (OAC). Nonetheless, HER2-blocking agents have failed to significantly improve the...

Biochemical and structural characterization of chlorite dismutase enzyme from Pseudomonas aeruginosa

Dimitrios V Nokas et al.

FEBS J. 2025 Jun 3. doi: 10.1111/febs.70151. Online ahead of print.

Tuesday, June 3, 2025

Industrialization and urbanization have caused serious contamination of water bodies, and the removal of chemical contaminants has become a major challenge. Chlorite is a harmful anthropogenic compound with a serious...

A guide to heat shock factors as multifunctional transcriptional regulators

Hendrik S E Hästbacka et al.

FEBS J. 2025 Jun 2. doi: 10.1111/febs.70139. Online ahead of print.

Monday, June 2, 2025

The heat shock factors (HSFs) form a family of transcription factors, which are evolutionarily conserved in eukaryotes. They are best known as transcriptional regulators of molecular chaperone genes, including those...

Proliferation of Human Cervical Cancer Cells Responds to Surface Properties of Bicomponent Polymer Coatings

Emil Rosqvist et al.

Nanomaterials (Basel). 2025 May 9;15(10):716. doi: 10.3390/nano15100716.

Tuesday, May 27, 2025

The proliferation of human cervical cancer (Hela) cells was investigated on a series of nanostructured polymer latex surfaces. The physico-chemical properties of the surfaces, composed of mixtures of polystyrene and...

Dynamic regulation of integrin β1 phosphorylation supports invasion of breast cancer cells

James R W Conway et al.

Nat Cell Biol. 2025 May 26. doi: 10.1038/s41556-025-01663-4. Online ahead of print.

Monday, May 26, 2025

Integrins provide an essential bridge between cancer cells and the extracellular matrix, playing a central role in every stage of disease progression. Despite the recognized importance of integrin phosphorylation in...

Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin

Roope A Kallionpää et al.

Br J Cancer. 2025 May 20. doi: 10.1038/s41416-025-03055-9. Online ahead of print.

Tuesday, May 20, 2025

CONCLUSION: The cNFs are relatively quiescent, consistent with their benign nature and limited growth potential. The development of pharmacological therapy for cNFs requires overcoming the high similarity between cNFs and...

High-resolution live imaging of tardigrade response to anoxia

Anna-Mari Haapanen-Saaristo et al.

Micron. 2025 May 9;196-197:103847. doi: 10.1016/j.micron.2025.103847. Online ahead of print.

Wednesday, May 14, 2025

Tardigrades are well-known for their ability to tolerate extreme environmental conditions such as heat, drought and lack of oxygen by undergoing cryptobiosis. The molecular responses to stress have been studied...

All publications

Blog posts